BIM
XENT

BlackRock Investment Management’s Intersect ENT, Inc XENT Stock Holding History

BlackRock Investment Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.2M Buy
98,915
+426
+0.4% +$5.51K ﹤0.01% 2586
2016
Q3 		$1.56M Sell
98,489
-179
-0.2% -$2.7K ﹤0.01% 2363
2016
Q2 		$1.28M Buy
98,668
+39,853
+68% +$624K ﹤0.01% 2450
2016
Q1 		$1.12M Sell
58,815
-212
-0.4% -$3.84K ﹤0.01% 2407
2015
Q4 		$1.33M Buy
59,027
+495
+0.8% +$9.79K ﹤0.01% 2383
2015
Q3 		$1.37M Buy
58,532
+7,955
+16% +$220K ﹤0.01% 2359
2015
Q2 		$1.45M Buy
50,577
+32,419
+179% +$850K ﹤0.01% 2486
2015
Q1 		$469K Buy
18,158
+1,033
+6% +$23.6K ﹤0.01% 2995
2014
Q4 		$318K Buy
17,125
+328
+2% +$5.9K ﹤0.01% 3174
2014
Q3 		$260K Buy
+16,797
New +$253K ﹤0.01% 3207

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Investment Management's XENT Position: Q4 2016 in Review

BlackRock Investment Management increased its Intersect ENT, Inc (XENT) stake by 0.43% in Q4 2016, buying an estimated $5.51K and bringing the position to 98,915 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

BlackRock Investment Management first reported a position in XENT in Q3 2014 and has held it in 10 quarters since. The position peaked at $1.56M in Q3 2016. 104 funds tracked by Wall St. Rank hold XENT as of Q4 2016.

  • BlackRock Investment Management held 98,915 shares of Intersect ENT, Inc worth $1.2M as of Q4 2016.
  • BlackRock Investment Management bought 426 Intersect ENT, Inc shares in Q4 2016, an estimated $5.51K.
  • Intersect ENT, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2586 holding.
  • BlackRock Investment Management first reported a position in Intersect ENT, Inc in Q3 2014 and has held it in 10 quarters since.
  • BlackRock Investment Management's Intersect ENT, Inc position peaked at $1.56M in Q3 2016.
  • 104 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.